← Back to Search

Supportive Oncology Care at Home for Pancreatic Cancer

N/A
Waitlist Available
Led By Ryan Nipp, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial looks at a new way of providing at-home care and monitoring for pancreatic cancer patients undergoing pre-operative treatment.

Eligible Conditions
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rates of completion
Rates of study enrollment
Secondary outcome measures
Change in psychological distress
Change in quality of life longitudinally throughout the study
Change in symptom burden longitudinally throughout the study
+13 more
Other outcome measures
Dose intensity
Number of cycles of chemotherapy completed
Number of emergency department visits
+13 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Oncology Care at HomeExperimental Treatment1 Intervention
The Supportive Oncology Care at Home intervention entails the following: patient-reported symptoms, vital sign, and weight monitoring with appropriate triggers for phone calls and home visits by Medically Home based on a clinician-derived algorithm scheduled nursing visits for intravenous (IV) hydration during the course of chemotherapy; regular communication with oncology clinicians regarding care delivered at home to ensure continuity of care.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,245 Total Patients Enrolled
Stand Up To CancerOTHER
51 Previous Clinical Trials
40,234 Total Patients Enrolled
Ryan Nipp, MD, MPHPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025